Company Analysis

Agenus Inc. (AGEN)

Nasdaq: AGEN · Biological Products, (No Diagnostic Substances) · Lexington, MA · filing with the SEC since 1999
Grade4.5
◀ Past 3.5● Present 5.2▶ Future 4.5
1 est.

Who runs Agenus Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Armen Garo H
Chairman, Chief Executive Officer and Principal Financial Officer. First filing Feb 2006, latest Aug 12, 2026, 7 filings in all.
Officers reporting now
4
of 9 people with a filing in the last fifteen months
Directors reporting now
5
26 people on the record since 2006
Officerssales are open-market, Oct 2, 2025 to Oct 2, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Armen Garo HChairman, Chief Executive Officer and Principal Financial OfficerFeb 2006Aug 12, 2026none
Buell JenniferChairman of the Executive CounselJul 2017Aug 7, 2026none
O'Day Steven JChief Medical OfficerFeb 2021Aug 7, 2026none
Charette AustinPrincipal Accounting OfficerJan 2026Apr 28, 2026none
Directorssales are open-market, Oct 2, 2025 to Oct 2, 2026
NameRoleFirst filingLatest filingSales, 12 months
Harrison Thomas LdirectorAug 2024Oct 2, 2026none
Wright TimothydirectorDec 2006Oct 2, 2026none
Marcucci Marco TulliodirectorSep 2026Sep 16, 2026none
Corvese BriandirectorMar 2007Aug 11, 2026none
Hirsch Susan BdirectorOct 2020Aug 7, 2026none
Earlier names on the record18, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton AGEN · research, not advice